Skip to content
Search

Latest Stories

Parkinson's may be detectable 20-30 years before clinical diagnosis: Study

According to the researchers, the disease, often thought of as an illness of old age, in fact, starts in midlife and can go undetected for decades

Parkinson's may be detectable 20-30 years before clinical diagnosis: Study

Signs of Parkinson's disease could potentially be identified 20-30 years before symptoms appear, Australian researchers have said.

Utilising a biomarker named F-AV-133 in combination with PET (positron emission tomography) scans enables the diagnosis of Parkinson's disease and precise monitoring of neurodegeneration, researchers from the Florey Institute of Neuroscience and Mental Health in Melbourne said.


F-AV-133 is an imaging agent and has shown promise as a PET tracer for detecting and monitoring neurodegeneration in Parkinson's disease, a progressive neurological disorder characterised by tremors and impaired muscular coordination.

According to the researchers, the disease, often thought of as an illness of old age, in fact, starts in midlife and can go undetected for decades.

"Parkinson's disease is very hard to diagnose until symptoms are obvious, by which time up to 85 per cent of the brain's neurons that control motor coordination have been destroyed. At that point, many treatments are likely to be ineffective," said Kevin Barnham, professor at The Florey and lead researcher of the study published in the journal Neurology.

In their study, 26 patients already diagnosed to have Parkinson's disease and a control group of 12 people were scanned, along with 11 other people having Rapid Eye Movement sleep behaviour disorder (RBD), a strong indicator of the disease. All of them undertook two PET scans two years apart.

The researchers found that the PET scans showed a significant loss in the nerve cells or neurons in three key regions of the brain in individuals with the disease, even as no significant changes in their clinical symptoms were seen according to currently available diagnostic assessments.

The findings suggest that F-AV-133 is a more sensitive means of monitoring neurodegeneration than what is now available, the researchers said in their study.

Using mathematical modelling, they found that when clinical symptoms of the disease begin to show and are sufficient for diagnosis, approximately 33 years' worth of slow neuronal loss has already taken place.

However, only about 10.5 years' worth of this neuronal loss happens before the disease can be detected on a PET scan, they said. Thus, they say that this diagnostic technique could help detect Parkinson's disease more than 20 years sooner than clinical diagnosis.

RBD is a significant warning sign for early Parkinson's disease and people having RBD are known to often shout or thrash around, sometimes violently, in their sleep while acting out vivid and unpleasant dreams.

About half of people with Parkinson's have RBD and roughly 90 per cent of people with RBD are likely to develop a parkinsonian condition. If one has RBD, it is suggested that they consult with a sleep specialist or a neurologist.

(PTI)

More For You

Prada 2026 sandals

Prada acknowledges Indian influence behind its Spring Summer 2026 men’s footwear

Instagram/prada/iStock

Prada finally acknowledges Kolhapuri chappals inspired 2026 sandals after Indian backlash over Milan show

Quick highlights:

• Prada confirms Indian roots behind 2026 ‘leather sandals’ after controversy
• Indian artisans and officials accused the brand of cultural appropriation
• The footwear resembles traditional Kolhapuri chappals with GI status
• Prada says designs are still in development and open to dialogue with India

Keep ReadingShow less
Anna Wintour

Wintour’s style of leadership earned her the nickname “Nuclear Wintour”

Getty Images

Anna Wintour steps down as editor of US Vogue after 37 years

Key points

  • Anna Wintour steps down as editor of US Vogue after 37 years
  • She will remain Vogue’s global editorial director and hold senior roles at Condé Nast
  • Wintour transformed US Vogue into a global fashion authority
  • The 75-year-old has received numerous honours, including the Presidential Medal of Freedom

End of an era at US Vogue

Anna Wintour has stepped down as the editor of US Vogue, bringing to a close a 37-year tenure that redefined the publication and saw her become one of the most influential figures in global fashion.

The announcement was made on Thursday (26 June) during a staff meeting in New York. Wintour, 75, will no longer oversee the day-to-day editorial operations of Vogue’s US edition. However, she will continue to serve as Vogue’s global editorial director and Condé Nast’s chief content officer, maintaining senior leadership roles across the company.

Keep ReadingShow less
Nadiya Hussain

She also reassured her followers that “exciting” new projects are on the way

Getty Images

“I won’t always be grateful” says Nadiya Hussain after BBC axes her cookery show

Key points

  • Nadiya Hussain confirms BBC will not renew her cookery series
  • Bake Off winner challenges expectations to remain “grateful”
  • She says hard work and talent, not luck, brought her success
  • Celebrities, including Annie Lennox and Fearne Cotton, show support

BBC ends decade-long collaboration with Bake Off star

Nadiya Hussain has spoken out after the BBC decided not to commission another cookery programme with her. The popular TV chef, who won The Great British Bake Off in 2015, shared her views on social media, stating that she “won’t always be grateful” and should not be expected to remain silent about career setbacks.

The decision ends a nearly 10-year working relationship between the broadcaster and Hussain, who has hosted several well-received cookery shows under the BBC banner. In her latest Instagram video, she addressed the public’s reaction and emphasised her right to expect more from her career.

Keep ReadingShow less
weight loss injections UK

The importance of vigilance as demand for these weight loss and diabetes drugs continues to grow

iStock

Hundreds report pancreas issues linked to weight loss injections as UK launches safety study

Key points

  • Almost 400 reports of acute pancreatitis linked to weight loss and diabetes jabs have been filed in the UK
  • Most cases involve popular GLP-1 drugs including Ozempic, Wegovy, and Mounjaro
  • Health officials are investigating possible genetic causes behind the side-effects
  • Patients hospitalised with pancreatitis encouraged to report symptoms via MHRA’s Yellow Card scheme
  • Adverse drug reactions cost the NHS an estimated £2.2bn annually

Health watchdog investigates spike in serious side-effects from GLP-1 drugs

UK health authorities have launched a study into the side effects of popular weight loss and diabetes drugs following a spike in reported cases of acute pancreatitis. Nearly 400 reports have been received via the Medicines and Healthcare products Regulatory Agency’s (MHRA) Yellow Card scheme, which monitors side effects and adverse reactions related to medicines and medical devices.

The medicines involved are GLP-1 receptor agonists – including semaglutide (marketed as Ozempic and Wegovy), liraglutide, and tirzepatide (branded as Mounjaro). The Yellow Card data shows that 181 of the cases involved tirzepatide alone.

Keep ReadingShow less
M&S launches strawberries

M&S’s latest offering taps into both tradition and innovation

The Wire

M&S launches strawberries and cream sandwich ahead of Wimbledon

Summary

  • M&S unveils limited edition strawberries and cream sandwich for £2.80
  • Inspired by Japanese 'sweet sandos', it features Red Diamond strawberries and whipped cream cheese
  • Available in stores now, found in the savoury sandwich aisle
  • Launch coincides with Wimbledon and British strawberry season
  • Wimbledon increases strawberries and cream price for first time in 15 years

New summer sandwich from M&S

Marks & Spencer has launched a limited edition M&S strawberry sandwich, combining classic British summer flavours with a Japanese twist. Priced at £2.80, the strawberries and cream sandwich is available in M&S stores now.

The dessert-style sandwich features M&S’s exclusive Red Diamond strawberries, whipped cream cheese, and sweetened bread. Despite its sweet contents, the product is found in the savoury sandwich section of M&S Food halls.

Keep ReadingShow less